Katharyn Grant (US)
Amarin and FDA settle off-label suit
The Brand Protection Blog ·
Eleventh Circuit accepts viability of contributory false advertising claims
The Brand Protection Blog ·
Amarin wins injunction against FDA over off-label marketing
The Brand Protection Blog ·
Court declines to extend Lanham Act to standard setting organization’s disciplinary activities
The Brand Protection Blog ·
FDA releases final guidance for size, shape and other physical attributes of generic drugs
The Brand Protection Blog ·